1-10 of 10
Irina Zotova
Close
Sort by
Journal Articles

Russian Experience of Bosutinib Use in Chronic Myeloid Leukemia Patients in Routine Clinical Practice

Vasily Shuvaev, MD, Olga Vinogradova, MD PhD, Irina Martynkevich, MD PhD, Novitskaya Natalya, MD, Mikhail Fominykh, MD, Svetlana Tsareva, Dzhariyat Shikhbabaeva, Maria Pankrashkina, Mikhail Chernikov, Nikolay Sharkunov, MD PhD, Irina Zotova, MD, Vera Udaleva, MD PhD, Ekaterina Motyko, MD, Sergei Voloshin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5446.
https://doi.org/10.1182/blood-2018-99-114164
Published: 2018
Journal Articles

The Rate of Individual BCR-ABL Decline As an Optimized Predictor of Tyrosine Kinase Inhibitors Treatment Outcome in Chronic Phase CML Patients, Comparison with CML Prognostic Scores and Early Molecular Response Achievement

Mikhail Fominykh, MD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Grigory Tsaur, MDPhD, Natalya Bederak, Ekaterina Chelysheva, Oleg Shukhov, MD, Adhamjon Abdullaev, MD PhD, Vera Udaleva, MD, Regina Golovchenko, MD, Irina Zotova, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Ekaterina Petrova, Marina Ivanova, Lyudmila Martynenko, Elizaveta Kleina, Natalya Cybakova, Anna Turkina, Prof., MD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5150.
https://doi.org/10.1182/blood.V126.23.5150.5150
Published: 2015
Journal Articles

The Influence of Hemostasis Genetic Features on Thrombosis Rates in Patients with Polycythemia Vera

Dzhariyat Shikhbabaeva, Vasily Shuvaev, MD, Sergey Kapustin, PhD, Irina Martynkevich, MD PhD, Vera Udaleva, MD, Regina Golovchenko, MD, Tatyana Zamotina, Mikhail Fominykh, MD, Irina Zotova, Lyubov Polushkina, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5180.
https://doi.org/10.1182/blood.V126.23.5180.5180
Published: 2015
Journal Articles

Prognostic Value of the Rate of BCR-ABL Decline for Patients with Chronic Myelogenous Leukemia in Chronic Phase on Tyrosine Kinase Inhibitors Treatment

Vasily Shuvaev, MD, Mikhail Fominykh, Martynkevich Irina, PhD, Grigory Tsaur, MDPhD, Natalya Bederak, Ekaterina Chelysheva, MD, Oleg Shukhov, Alla Abdulkadyrova, Vera Udaleva, MD, Regina Golovchenko, Irina Zotova, Adhamjon Abdullaev, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Ekaterina Petrova, Lyudmila Martynenko, Elizaveta Kleina, Natalya Cybakova, MD, Marina Ivanova, MD, Anna G. Turkina, MD PhD, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 3148.
https://doi.org/10.1182/blood.V124.21.3148.3148
Published: 2014
Journal Articles

Ph-Negative Chronic Myeloproliferative Neoplasms – Population Analysis, a Single Center 10-years’ Experience

Vasily Shuvaev, MD, Irina Martynkevich, PhD, Alla Abdulkadyrova, Vera Udaleva, MD, Tatyana Zamotina, Mikhail Fominykh, Regina Golovchenko, Irina Zotova, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 5556.
https://doi.org/10.1182/blood.V124.21.5556.5556
Published: 2014
Journal Articles

Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

Kudrat Abdulkadyrov, Elza Lomaia, Natalia Lazorko, Vasiliy Shuvaev, Alla Abdulkadyrova, Irina Martinkevich, Elena Usacheva, Vera Udalieva, Irina Zotova, Elena Machulaitene, Natalia Ilina, Elena Karyagina, Irina Kholopova, Ekaterina Romanova, Eugenia Sbityakova, Tatiana Shneider, Andrey Zaritskey
Journal: Blood
Blood (2012) 120 (21): 4432.
https://doi.org/10.1182/blood.V120.21.4432.4432
Published: 2012
Journal Articles

Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

Irina Dyagil, Elza Lomaia, Kudrat Abdulkadirov, Elena Goryunova, Natalia Lazorko, Ekaterina Romanova, Eugenia Sbityakova, Alla Abdulkadirova, Irina Martinkevich, Vera Udalieva, Elena Usacheva, Irina Zotova, Vasiliy Shuvaev, Elena Machulaitene, Ekaterina Poznyak, Maria Ivanova, Natalia Ilina, Elena Koryagina, Tatiana Shneider, Svetlana Stepanova, Irina Dmitrenko, Natalia Babkina, Tatiana Perekhrestenko, Zvenyslava Masliak, Andrey Zaritskey
Journal: Blood
Blood (2011) 118 (21): 4452.
https://doi.org/10.1182/blood.V118.21.4452.4452
Published: 2011
Journal Articles

Only Time Before the Beginning of Treatment and Time to Achieve CCyR Influence the Stability of CCyR In CML-CP Patients On Imatinib Therapy.

Kudrat Abdulkadyrov, Elza Lomaia, Alla Abdulkadyrova, Vera Udalieva, Dgariyat Shikhbabaeva, Elena Usacheva, Irina Zotova, Elena Machulaitene, Maria Ivanova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Evgenia Salamatova, Natalia Lazorko, Irina Martynkevich, Vasiliy Shuvaev, Andrey Zaritskey
Journal: Blood
Blood (2010) 116 (21): 4476.
https://doi.org/10.1182/blood.V116.21.4476.4476
Published: 2010
Journal Articles

6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreatment.

Kudrat Abdulkadirov, Elza Lomaia, Vasiliy Shuvaev, Alla Abdulkadirova, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey
Journal: Blood
Blood (2009) 114 (22): 4278.
https://doi.org/10.1182/blood.V114.22.4278.4278
Published: 2009
Journal Articles

Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region).

Kudrat Abdulkadirov, Elza Lomaia, Alla Abdulkadirova, Vasiliy Shuvaev, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey
Journal: Blood
Blood (2009) 114 (22): 4288.
https://doi.org/10.1182/blood.V114.22.4288.4288
Published: 2009